For this week's Tuesday Licensing Forum @2pm we will have a special presentation from the McBee Moore & Vanik IP law firm, a National Institutes of Health (NIH) contract law firm based in Frederick, MD and McLean, VA.
Federal laboratories seek patent protection for their discoveries in order to support commercial development by licensees so selection of an appropriate patent filing strategy to provide for this is very important. While there are many patent filing and prosecution options available to laboratories, how do you decide which ones are actually appropriate for early stage technologies? This seminar will provide an overview of the various options available and provide guidance on how to select the best option useful in the protection and licensing of your lab's early stage technologies.
David l. Vanik, PhD, Partner
David Vanik is a registered patent attorney specializing in patent prosecution and counseling, post grant procedures before the United States Patent and Trademark Office ("USPTO"), and patent portfolio strategy in the chemical and biotechnology arts. David enjoys the technological nature of practicing patent law and takes pride in assisting clients from around the globe in achieving their respective legal and business objectives.
W. Brett Stauffer, Counsel
Brett Stauffer is a patent attorney in the firm and has experience in a variety of patent and trademark matters. Brett's patent prosecution experience includes drafting and prosecuting applications in the chemical, biochemical, pharmaceutical, nutraceutical, and engineering fields. Brett also provides patent counseling services such as drafting patentability, freedom-to-operate, and invalidity opinions and performing due diligence for patent portfolios subject to mergers and acquisitions.
Webex link: https://nih.webex.com/webappng/sites/nih/meeting/download/5F55A6EFB703BC...
Meeting ID: 623 329 789
Join by phone: 1-650-479-3208